Clinical Trials Sponsored by Teva Pharma

Total 9022 results

Teva Pharmaceuticals USA

Completed

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Sertraline Hydrochloride 100 mg Tablets, Fed

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Sertraline Hydrochloride 100 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Aurelius Omlin
University Hospital, Zürich; Teva Pharma

Terminated

Carboplatin in Castration-resistant Prostate Cancer (PRO-PLAT)

Prostatic Neoplasm

Switzerland
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Teva Neuroscience, Inc.

Completed

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients (ENCORE)

Multiple Sclerosis
Teva Women's Health

Completed

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Pregnancy Prevention

United States
Teva Neuroscience, Inc.

Completed

Therapy Optimization in Multiple Sclerosis (MS) (TOP MS)

Multiple Sclerosis

United States
Teva Neuroscience, Inc.

Completed

Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

Parkinson's Disease
Teva Neuroscience, Inc.

Completed

A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

Multiple Sclerosis
Teva Pharmaceuticals USA
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal

United States, Bulgaria, Czechia, Georgia, Germany, Hungary, Poland, Russian Federation, Slovakia, Ukraine
Teva Neuroscience, Inc.

Completed

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

Multiple Sclerosis

United States
Teva Neuroscience, Inc.

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

Multiple Sclerosis
Teva Pharmaceuticals Europe

Completed

Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease (SPRINT)

Chronic Obstructive Pulmonary Disease | Asthma

Croatia, Denmark, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom
Teva Women's Health

Completed

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Oral Contraceptive | Hemostasis

United States, Italy
Teva Neuroscience, Inc.

Completed

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Parkinson's Disease
Teva Neuroscience, Inc.

Completed

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

Multiple Sclerosis
McMaster University
Teva Canada

Completed

Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma

Asthma; Eosinophilic

Canada
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
Teva Pharmaceutical Industries, Ltd.

Completed

TL011 in Severe, Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Czechia, Hungary, Italy, Spain, United Kingdom
Teva Pharmaceutical Industries, Ltd.

Completed

Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Belgium, France, Germany, Israel, Italy, United Kingdom
Teva Pharmaceutical Industries, Ltd.

Terminated

A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

Growth Hormone-Deficiency

Belarus, Bulgaria, Georgia, Greece, Hungary, Israel, Poland, Romania, Russian Federation, Serbia, Spain, Turkey, Ukraine
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Teva Pharmaceutical Industries, Ltd.

Terminated

An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease

Relapsing Remitting Multiple Sclerosis

Czechia, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
Universitaire Ziekenhuizen KU Leuven
Eli Lilly and Company; Kom Op Tegen Kanker; Teva Pharma

Recruiting

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer (ABBICAR)

Triple Negative Breast Neoplasms

Belgium
Teva Neuroscience, Inc.
Teva Branded Pharmaceutical Products R&D, Inc.; TransPharma Medical

Completed

A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency

Growth Hormone Deficiency
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg

Asthma

United States
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

Atrophic Vaginitis

United States
Georgetown University
Teva Neuroscience, Inc.

Completed

A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy (RECOGNIZE)

Parkinson's Disease

United States
Amphia Hospital
Sanofi; TEVA Pharmachemie

Unknown

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) (OCTIMS)

Multiple Sclerosis

Netherlands
Franciscus Gasthuis
Teva Pharmaceuticals USA

Recruiting

Expertise Asthma COPD Program With Digital Support (EXACT@home)

Asthma

Netherlands
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants

Asthma

United States
University Hospital, Bordeaux
TEVA laboratories

Completed

Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRI (SCI-COG)

Multiple Sclerosis | Brain MRI | Clinically Isolated Demyelinating Syndromes | Cognitive Deficiencies

France
Endo Pharmaceuticals
Teva Pharmaceuticals USA

Completed

A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering

Stuttering

United States
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma

Asthma

United States
Actavis Inc.
Teva Pharmaceuticals USA

Completed

A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"

Rosacea

United States
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Head Lice

United States
Emory University
Teva Pharmaceuticals USA

Terminated

Omacetaxine for Consolidation and Maintenance

Acute Myelogenous Leukemia (AML)

United States
Brown University
Teva Pharmaceuticals USA

Completed

The Effect of Rasagiline on Cognition in Parkinson's Disease

Parkinson's Disease

United States
Tera Group

Not yet recruiting

Breath Samples Collection Clinical Trial, for Development of the TERA BioStation T101, Intended for CoV-19 Exhalation Products Detection.

COVID-19
Tera Group

Recruiting

Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.

COVID-19

United Kingdom
Tiva Group

Completed

Morphine Consumption in the Obese Patients

Anesthesia Morbidity | Obesity, Morbid | Opioid Use | Post Operative Pain | Pharmacological Action

Spain
Teva Branded Pharmaceutical Products R&D, Inc.
H. Lundbeck A/S; Teva Neuroscience, Inc.

Completed

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Parkinson's Disease

United States, Argentina, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Romania, Spain, United Kingdom
Tera Group

Recruiting

Validation of TERA Bio Station T101 of COVID-19 Tested Population.

COVID-19

Turkey
Tiva Group

Unknown

Use of the Nasal Cannula During COVID-19

COVID 19

Argentina
Teva Neuroscience, Inc.
H. Lundbeck A/S

Completed

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease (ANDANTE)

Parkinson's Disease

United States
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Osteoarthritis, Knee | Osteoarthritis, Hip

United States, Poland, United Kingdom

Clinical Trials Sponsored by Teva Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations